Skyrizi
The latest news about Skyrizi: headlines, AI summaries and the full story from every source.
- AbbVie Outlines Growth in SKYRIZI, RINVOQ and Pipeline Advances at Wells Fargo Conference
- Skyrizi Growth Deceleration Could Test AbbVie Stock
- Johnson & Johnson Launches New Plaque Psoriasis Treatment Competing with AbbVie’s Skyrizi
- Johnson & Johnson Launches New Plaque Psoriasis Treatment to Challenge AbbVie’s Skyrizi
- A Small Biotech Shows Competitive Potential Against AbbVie's Key Drug
- AbbVie's Q1 Revenue Surpasses Expectations with Strong Performance in Immunology
- AbbVie Exceeds Quarterly Revenue and Profit Expectations as Newer Immunology Drugs Offset Humira Decline
- AbbVie Submits FDA Application for Subcutaneous Version of Skyrizi